AB21® is Nicolas Hall's CHC innovation of the month

19 August  2021 – 2 min read

AB21® breakthrough clinical results have caught the attention of Nicholas Hall, that has presented the probiotic formulation as Innovation of the month.

Nicholas Hall’s CHC Insight Europe covers latest healthcare news of Europe’s OTC (over-the-counter) consumer healthcare market, with focus on B2B (business-to-business) companies. A monthly compilation of reports and articles on key OTC trends and developments is delivered to Nicolas Hall’s subscribers, offering an in-depth and exclusive insight of the market.

July’s issue of Nicolas Hall’s CHC Insight Europe presents AB21 in its Innovation Round-up, as a probiotic formulation that is helping elevate the probiotic category from digestive remedies to more complex and relevant immune booster solutions.

As extracted directly from July’s issue:

For more information about AB21® probiotic, visit its product website (directed to healthcare professionals and industry members only).

Authors: Claudia Prat (Human Biologist)